Christopher Selby

Christopher Selby serves as Assistant Professor in the Department of Pharmacy Practice at Texas Tech University Health Sciences Center in Dallas, Texas, a position held continuously since March 2018.

He obtained his Pharm.D. from Southern Illinois University Edwardsville School of Pharmacy during 2010-2014, establishing his clinical pharmacy foundation.

Dr. Selby's research specializes in oncology therapeutics, with critical focus areas:

• Immune checkpoint inhibition strategies for melanoma treatment
• CDK4/6 inhibitor applications in advanced breast cancer
• Clinical translation of targeted cancer therapies
• Management of treatment-related adverse events
• Personalized oncology drug regimens

His publication history reveals consistent scholarly activity in high-impact pharmacotherapy journals, demonstrating expertise in synthesizing clinical evidence for emerging cancer treatments through systematic reviews. Recent work emphasizes practical implementation challenges of novel oncology agents in real-world practice settings.